This document discusses the pharmacological, surgical, dietary, and nursing management of myasthenia gravis. Pharmacological treatments include immunosuppressants like azathioprine to prevent organ rejection, corticosteroids like prednisone to suppress the immune system, and cholinesterase inhibitors like pyridostigmine as first-line therapy. Plasmapheresis removes antibodies against blood proteins before transplantation. Surgical management may include thymectomy. Dietary management focuses on reducing protein and dairy intake while increasing fruits, vegetables, and foods high in potassium. Nursing care addresses ineffective breathing, impaired communication and mobility, risk of aspiration, and disturbed sensory perception. Potential complications include myasthenic crisis requiring ventilation and